HBIO
NASDAQ · Life Sciences Tools & Services
Harvard Bioscience Inc
$6.15
+0.03 (+0.41%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+481.3% upside
Low Target
$24.20
Average Target
$35.75
High Target
$46.73
Current Price
$6.15
Current
$6.15
$6.15
Target
$35.75
$35.75
$24.20
$35.75 avg
$46.73
Scenario Analysis
Bear Case
$24.20
293.5%
Low target
Base Case
$35.75
+481.3%
Avg target
Bull Case
$46.73
+659.8%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$9.40
-34.6% from high
52-Week Low
$3.75
+64.0% from low
Target vs 52W High
$35.75
+280.3% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 34 | 85% | $369.21 | -26.4% |
| DHR | Strong Buy | 30 | 90% | $158.11 | -17.0% |
| A | Strong Buy | 28 | 79% | $64.69 | -51.3% |
| WAT | Buy | 28 | 57% | $189.60 | -49.4% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -57.1% |
| ILMN | Buy | 28 | 61% | $169.36 | -3.7% |
| MTD | Hold | 20 | 50% | $170.43 | -86.7% |
| WST | Strong Buy | 22 | 82% | $136.24 | -62.1% |